After last week’s bungled pre-launch of BioHub, the proposed anti-diabetic sponge, the DRI has decided to rebrand and re-prelaunch with another pre-announcement. The new BiUD will be available for pre-order sometime in the next 5-7 years, after which it will undergo a rigorous FDA approvals process. There is no word yet on the rumor that the DRI is also developing the “Biaphragm,” a diabetes cure that people with diabetes can use without the aid of a physician.
(“What the what?” you ask. Don’t worry; Jacquie explains all in the best possible way.)